← Medication Database
Oncology

Alymsys

Generic: bevacizumab-maly

Manufacturer: Amneal Pharmaceuticals  ·  Program: Amneal PATHways

Apply for Assistance

Eligibility Criteria

Insurance Requirement

See program details

Residency

US residency required

Program Information

Processing Time

2–8 weeks

Delivery Method

Varies by program

Application Method

Online

Indicated For

Metastatic colorectal cancer, Non-squamous non-small cell lung cancer, Recurrent glioblastoma, Metastatic renal cell carcinoma, Persistent/recurrent/metastatic cervical cancer, Epithelial ovarian/fallopian tube/primary peritoneal cancer

About This Medication

# Amneal PATHways Patient Guide: How to Get Alymsys (bevacizumab-maly) at Low or No Cost Alymsys (bevacizumab-maly) is a biosimilar to Avastin, used to treat certain cancers like colorectal, lung, kidney, and ovarian cancers by blocking blood vessel growth in tumors.[1][4] The **Amneal PATHways** program from Amneal Pharmaceuticals offers patient support, including the Patient Assistance Program (PAP) for **free medication** up to one year for eligible U.S. patients facing financial hardship.[1][2][3] ## Who Qualifies for Amneal PATHways and PAP? The program supports U.S. residents (including Puerto Rico and U.S. Virgin Islands) prescribed Alymsys.[2][5] It includes two main paths: - **PATHways Co-pay Program**: For **commercially insured** patients (not Medicare, Medicaid, or uninsured). Pay **as little as $0** per treatment. No income limits.[7] - **Patient Assistance Program (PAP)**: Free Alymsys for **uninsured, underinsured**, or those in financial hardship. Must meet income criteria and residency rules. Medicare Part D patients need to have spent at least **3% of annual household income** out-of-pocket on prescriptions.[3][9] **Key eligibility notes**: - U.S. resident only.[5] - Valid prescription required.[5] - Program determines exact income thresholds based on **household income** and Federal Poverty Level (FPL); call for details as specifics vary.[3][9][1] ## About Alymsys (bevacizumab-maly) **Alymsys** is an injectable biosimilar to Avastin (bevacizumab), approved for the same uses: metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, cervical cancer, and epithelial ovarian/fallopian tube/primary peritoneal cancer.[4] It works by inhibiting vascular endothelial growth factor (VEGF), starving tumors of blood supply. Administered IV in a healthcare setting, typically every 2-3 weeks. Common side effects include high blood pressure, bleeding, and infusion reactions—discuss risks with your doctor.[4] As a **biosimilar**, Alymsys matches Avastin in safety, efficacy, and quality but may cost less.[1] The reference product is **Avastin**.[program details] ## Income Eligibility Breakdown Exact FPL percentages aren't publicly listed and depend on household size—contact the program for your situation.[3] General PAP criteria from Amneal programs: | Household Size | Estimated Max Income (e.g., 400-500% FPL)* | Medicare Part D Requirement | |---------------|---------------------------------------------|-----------------------------| | Individual | ~$60,000-$75,000 annually | ≥3% household income spent on Rx |[3][9] | Couple | ~$80,000-$100,000 | ≥3% household income spent on Rx |[3] | Family of 3 | ~$100,000-$125,000 | ≥3% household income spent on Rx |[3] | Family of 4 | ~$120,000-$150,000 | ≥3% household income spent on Rx |[3] *Estimates based on 2026 FPL; **call 1-877-764-9021** to confirm exact thresholds, as they 'meet program eligibility requirements.'[2][3][9] Co-pay program has **no income requirements**.[7] ## Insurance Requirements - **Commercial insurance**: Eligible for co-pay card ($0 copay possible).[7] - **Medicare Part D**: Eligible for PAP if out-of-pocket spend ≥3% income; not for co-pay program.[3][9] - **Uninsured/underinsured**: PAP primary option.[2] - **Medicaid/VA**: Generally ineligible.[7] PATHways specialists investigate benefits and explore options.[1][7] ## Step-by-Step Application Process 1. **Get Prescribed**: Doctor prescribes Alymsys and discusses PATHways.[1][4] 2. **Enroll in PATHways**: Call **866-426-6325** or visit provider portal; opt into SMS for updates.[1][2] 3. **Speak to Access Specialist**: They assess insurance, affordability, and PAP eligibility.[1][3] 4. **For PAP**: - Download/complete application (patient sections 1-3).[5][9] - Doctor completes/sends original signed prescription.[5] - Gather **financial docs** (tax returns, pay stubs, proof of Rx spend for Medicare).[5][9] - **Fax/mail** to: Amneal PAP, PO Box 220586, Charlotte, NC 28222 (Fax: 1-877-764-9022).[5] 5. **Follow Up**: Answer calls from 1-866-426-6325; save number.[1] Call **1-877-764-9021** (M-F, 8AM-5PM CST) for PAP support.[2] ## Timeline and Delivery - **Approval**: Varies; opt into SMS for status. PAP up to weeks for review.[1][5] - **Duration**: Free meds shipped to **home** for **up to 1 year**.[2][3][5] - **Renewal**: Program sends form before expiration.[5][9] ## Alternatives if Denied - **Appeal**: PATHways helps with insurer denials/PA appeals.[3] - **Co-pay switch**: If commercially insured.[7] - **Biosimilar alternatives**: Avastin (reference).[program details] - **Other resources**: Third-party aid via specialists.[1] - **Reapply**: Check eligibility changes.[2] ## Disclaimer This guide summarizes publicly available info as of 2026; eligibility/terms change. Not medical/financial advice. Confirm details with Amneal at 1-877-764-9021 or 866-426-6325. Consult your doctor. Program not insurance; limits apply.[1][2][5][7] (Word count: 950)

Program information last verified: March 30, 2026

Ready to apply for Alymsys assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications